Cargando…
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations
Well-differentiated/dedifferentiated liposarcoma is a common soft tissue sarcoma with approximately 1500 new cases per year. Surgery is the mainstay of treatment but recurrences are frequent and systemic options are limited. ‘Tumor genotyping’ is becoming more common in clinical practice as it offer...
Autores principales: | Somaiah, Neeta, Beird, Hannah C, Barbo, Andrea, Song, Juhee, Mills Shaw, Kenna R., Wang, Wei-Lien, Eterovic, Karina, Chen, Ken, Lazar, Alexander, Conley, Anthony P., Ravi, Vinod, Hwu, Patrick, Futreal, Andrew, Simon, George, Meric-Bernstam, Funda, Hong, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929434/ https://www.ncbi.nlm.nih.gov/pubmed/29731991 http://dx.doi.org/10.18632/oncotarget.24924 |
Ejemplares similares
-
Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin
por: Beird, Hannah C., et al.
Publicado: (2018) -
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard
por: Livingston, J. A., et al.
Publicado: (2017) -
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Scattered genomic amplification in dedifferentiated liposarcoma
por: Mandahl, Nils, et al.
Publicado: (2017)